6Demonty G, Bernard - Marry C, Puglisi F, et al. Progress and new standards of care in the management of HER - 2 positive breast cancer[ J ]. Eur J Cancer,2007, 43:497 -509.
7Strauss B. Best hope or last hope access t o phase Ⅲ clini2cal trials of HER - 2/neu for advanced stage breast cancer patients[J]. J Advanced Nursing, 2000, 31:259 - 266 ..
8Slamon DF, Clark GM, Wong SG, et al. Human breart cancer: correlation of relapse and surcival withe amplification of the her - 2/ncu ncogcne[ J ]. Science, 1987,235 ( 1785 ) : 177 - 182.
9Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER -2/neu proto - oneogene in human breast and ovarian cancer [J]. Science,1989,244:707 12.
10Wolff AC, Hammond EH, Schwartz JN, et al. American Scciety of Clinical Oncology/College of American Pathologists guide line recommendations for human epidermal growth factor receptor teating in breast cancer[J]. Clin Oncol ,2007,25:118 45.
